| EP2 antagonists (2011–2021): a decade’s journey from discovery to therapeutics MN Sluter, R Hou, L Li, N Yasmen, Y Yu, J Liu, J Jiang Journal of medicinal chemistry 64 (16), 11816-11836, 2021 | 23 | 2021 |
| Inhibiting the PGE2 Receptor EP2 Mitigates Excitotoxicity and Ischemic Injury L Li, Y Yu, R Hou, J Hao, J Jiang ACS Pharmacology & Translational Science 3 (4), 635-643, 2020 | 23 | 2020 |
| SLC14A1: a novel target for human urothelial cancer R Hou, X Kong, B Yang, Y Xie, G Chen Clinical and Translational Oncology 19, 1438-1446, 2017 | 23 | 2017 |
| Inducible Prostaglandin E Synthase as a Pharmacological Target for Ischemic Stroke JJ Lexiao Li, Nelufar Yasmen, Ruida Hou, Seyoung Yang, Jae Yeol Lee, Jiukuan ... Neurotherapeutics, https://doi.org/10.1007/s13311-022-01191, 2022 | 15* | 2022 |
| PGE2 receptors in detrusor muscle: Drugging the undruggable for urgency R Hou, Y Yu, J Jiang Biochemical pharmacology 184, 114363, 2021 | 15 | 2021 |
| Ablation of Siglec-E augments brain inflammation and ischemic injury JJ Lexiao Li, Yu Chen, Madison N. Sluter, Ruida Hou, Jiukuan Hao, Yin Wu ... Journal of Neuroinflammation 19, 191, 2022 | 10 | 2022 |
| Identification of a novel UT-B urea transporter in human urothelial cancer R Hou, M Alemozaffar, B Yang, JM Sands, X Kong, G Chen Frontiers in physiology 8, 245, 2017 | 10 | 2017 |
| Sectional anatomy aid for improvement of decompression surgery approach to vertical segment of facial nerve Y Feng, YQ Zhang, M Liu, L Jin, M Huangfu, Z Liu, P Hua, Y Liu, R Hou, ... Journal of Craniofacial Surgery 23 (3), 906-908, 2012 | 9 | 2012 |
| Targeting EP2 receptor with multifaceted mechanisms for high-risk neuroblastoma R Hou, Y Yu, MN Sluter, L Li, J Hao, J Fang, J Yang, J Jiang Cell Reports 39 (16), https://doi.org/10.1016/j.celrep.2022.11, 2022 | 8 | 2022 |
| Inhibition of TRPC3 channels by a novel pyrazole compound confers antiseizure effects JJ Marwa M. Nagib, Sicheng Zhang, Nelufar Yasmen, Lexiao Li, Ruida Hou, Ying ... Epilepsia, https://doi.org/10.1111/epi.17190, 2022 | 8* | 2022 |
| Prostaglandin E2 in neuroblastoma: Targeting synthesis or signaling? R Hou, Y Yu, J Jiang Biomedicine & Pharmacotherapy 156 (113966), https://doi.org/10.1016/j.biopha …, 2022 | 6 | 2022 |
| Association between androgen receptor gene polymorphisms and testicular germ cell tumor: A systematic review and meta-analysis J Qin, N Cui, R Hou, T Liu, H Sun, Y Liu, L Wang, J Ni, X Gu Journal of Cancer Research and Therapeutics 15 (Suppl 1), S60-S68, 2019 | 5 | 2019 |
| Prostaglandin receptor EP2 is a novel molecular target for high-risk neuroblastoma R Hou, Y Yu, DT Nguyen, MN Sluter, L Li, J Yang, J Jiang BioRxiv, 2020.02. 24.963108, 2020 | 3 | 2020 |
| 大肠癌相关基因突变与大肠癌遗传易感性的研究 侯睿智， 舒振波， 侯睿达， 刘艳 中国实验诊断学 21 (1), 173-176, 2017 | 1 | 2017 |
| CD200 和 CD200R 在膀胱和肾脏肿瘤表达的研究 侯睿达， 安治国， 刘俊婷， 毛静涛， 孔祥波， 侯治富 中国实验诊断学 20 (10), 1661-1663, 2016 | 1 | 2016 |
| JW-1-283 inhibits melanoma tumor growth via stabilization of the p53 pathway WL Yang Xie, Ruida Hou, Kelli L. Hartman, Jianxiong Jiang, Zhongzhi Wu Genes & Diseases, https://doi.org/10.1016/j.gendis.2023.06, 2023 | | 2023 |
| Prostaglandin E2 receptor EP2: A novel target for high-risk neuroblastoma. R Hou, Y Yu, J Yang, J Jiang In: Proceedings of the American Association for Cancer Research Annual …, 2023 | | 2023 |
| The inducible prostaglandin E synthase (mPGES-1) in neuroinflammatory disorders JJ Madison N Sluter, Qianqian Li, Nelufar Yasmen, Yu Chen, Lexiao Li, Ruida ... Experimental Biology and Medicine, https://journals.sagepub.com/doi/10.1177, 2023 | | 2023 |
| Targeting Prostaglandin E2 Receptor EP2 for Treatment of High-Risk Neuroblastoma R Hou The University of Tennessee Health Science Center, 2023 | | 2023 |
| Association between androgen receptor gene polymorphisms and testicular germ cell tumor: a systematic review and meta-analysis. QJX Qin JiaXuan, CN Cui Ni, HRD Hou RuiDa, LT Liu Tie, ... | | 2019 |
Jianxiong JiangUniversity of Tennessee College of PharmacyVerified email at uthsc.edu
